May 6, 2016
Recommended Topic Related To:

Paremyd

"Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.

Patients with LAL deficiency (also known as Wolman disea"...

A A A

Paremyd




Paremyd Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 3/21/2016

Paremyd (hydroxyamphetamine Hydrobromide 1% and tropicamide 0.25%) is a topical mydriatic used for pupil dilation (mydriasis) in routine diagnostic procedures and in conditions where short-term pupil dilation is desired. Common side effects of Paremyd include:

  • increased intraocular (eye) pressure
  • stinging
  • dryness of the mouth
  • blurred vision
  • sensitivity to light
  • slow heart rate
  • headache
  • allergic reactions
  • nausea
  • vomiting
  • pale skin (pallor)
  • muscle rigidity
  • central nervous system disturbances, or
  • behavioral disturbances.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Paremyd FDA Prescribing Information: Side Effects
(Adverse Reactions)

SIDE EFFECTS

Increased intraocular pressure has been reported following use of mydriatics. Transient stinging, dryness of the mouth, blurred vision, photophobia with or without corneal staining, tachycardia, headache, allergic reactions, nausea, vomiting, pallor, and muscle rigidity have been reported with the use of tropicamide and/or hydroxyamphetamine hydrobromide, and thus may occur with PAREMYD® (hydroxyamphetamine hydrobromide, tropicamide) Solution. Central nervous system disturbances have also been reported. Psychotic reactions, behavioral disturbances, and vasomotor or cardiorespiratory collapse have been reported with the use of anticholinergic drugs. Rare but serious cardiovascular events, including death due to myocardialinfarction, ventricular fibrillation and significant hypotensive episodes have occurred shortly following PAREMYD® (hydroxyamphetamine hydrobromide, tropicamide) instillation.

Read the entire FDA prescribing information for Paremyd (Hydroxyamphetamine Hydrobromide, Tropicamide)

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.